Molecular inhibitors found to arrest tumor cell proliferation in lung cancer...
Inhibition of the oncogenic kinase AKT, a key protein governing the cell cycle, was found to arrest cancer cell proliferation and triggered their programmed death by apoptosis.
View ArticleCombined treatment prolongs survival in mouse models of malignant mesothelioma
Combined treatment with two cancer immunotherapy drugs - one a novel immune modulator and one that focuses and activates the antitumor immune response - significantly prolonged survival in mouse models...
View ArticleInternational researchers succeed in stopping growth of mesothelioma in model...
An international team led by researchers from the Technion-Israel Institute of Technology and NYU Langone Health have succeeded in stopping the growth of mesothelioma in model animals by inhibiting the...
View ArticleStudy finds increase in lifestyle-related cancers over the past decade
Lifestyle-related cancers, such as lung, colorectal, and skin cancers, have increased globally over the past decade, according to the most comprehensive analysis of cancer-related health outcomes and...
View ArticleInhibition of miR-24-3p may serve as potential treatment target for mesothelioma
Inhibition of miR-24-3p reduced growth of cancer cells and was found to regulate proteins as a potential treatment target for Mesothelioma.
View ArticleResearchers find how NF2 gene mutations lead to out-of-control cellular...
A team of Massachusetts General Hospital Cancer Center researchers has determined one way that mutations in a gene involved in a rare, hereditary cancer syndrome lead to out-of-control cellular...
View ArticleVerastem doses first patient in Phase I/II clinical trial of duvelisib in...
Verastem, Inc., operating as Verastem Oncology, a biopharmaceutical company focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients, today...
View ArticleBAP1 protein serves as tumor suppressor gene in kidney, eye, bile duct and...
Researchers at The University of Texas MD Anderson Cancer Center have shown how BRCA-associated protein 1 (BAP1) serves as a tumor suppressor gene in kidney, eye, bile duct, mesothelioma and other...
View ArticleNew discovery links proteins that control DNA packaging and cancer development
University of Otago scientists have unraveled the 3D structure of two proteins, potentially providing answers as to why some people may be at risk of developing specific cancers.
View ArticleNCI grant awarded to Abramson Cancer Center to study CAR T cells In solid tumors
A new program project grant from the National Cancer Institute will fund research by the Translational Center of Excellence for Lung Cancer Immunology at the Abramson Cancer Center of the University of...
View ArticlePeople with rare cancers can benefit from genomic profiling, shows research
New research has shown that many Australians with rare cancers can benefit from genomic profiling. The findings of the patient-driven trial are being presented today at the Clinical Oncology Society of...
View ArticleAsbestos found in most NHS hospitals finds BBC inquiry
An inquiry led by the BBC has found that nine out of ten NHS hospitals have asbestos. The inquiry included 211 trust hospitals of which 198 agreed that they used asbestos in their hospital.
View ArticleResearchers discover new mechanism behind spread of malignant pleural...
Malignant pleural mesothelioma is divided into three subtypes, one of which is particularly aggressive. Researchers from the Comprehensive Cancer Center of MedUni Vienna and Vienna General Hospital...
View ArticleWorld's largest AI-powered medical research network launched by OWKIN
OWKIN today announced the world's largest AI-powered medical research network. The OWKIN Loop Network is comprised of 44 prestigious hospitals and research institutions across the US and Europe,...
View ArticleNew combination therapy found to be well tolerated in patients with...
A phase I clinical trial that set out to assess the safety of a new combination therapy for a type of aggressive brain tumour has found the treatment to be well tolerated in patients.
View ArticleResearch demonstrates clinical utility of ddPCR-powered liquid biopsy at 2019...
New research demonstrating the clinical utility of Bio-Rad's Droplet Digital PCR powered liquid biopsy will be presented this week during the 2019 American Association for Cancer Research Annual...
View ArticleMesothelioma patients twice as likely to survive when treated with high dose...
Mesothelioma patients are twice as likely to survive for two years or longer, if they are treated with a high dose of radiation to the affected side of the trunk, according to research presented at the...
View ArticleNew study points out simple problem with existing model of cancer
The saying "God doesn't play dice" is meant to suggest that nothing happens by chance. On the other hand, cancer seems like the ultimate happenstance: Don't we all have a 43-year-old, vegan, triathlete...
View ArticleResearchers discover novel cancer-promoting molecular mechanism
A novel cancer-promoting molecular mechanism has been discovered by Pierluigi Scalia, M.D., Ph.D., with his co-workers at the Sbarro Institute for Cancer Research and Molecular Medicine, Division of...
View ArticleRemoving asbestos from schools likely to increase cases of mesothelioma
Removing asbestos from every school in the UK could result in more deaths from mesothelioma than if the asbestos was left in place, claims expert.
View Article